Key Features

  • Breast density assessment
  • Image quality assessment
  • Risk score

General Information

Product name

intelliMammo™

Company

Subspeciality

Breast

Modality

Mammography

Disease targeted

Breast cancer

Main task

Not specified

Technical Specifications

Population

Not specified

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class I

Not verified by Health AI Register
FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Not verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

01-2017

AI Platforms

Blackford Analysis, Nuance

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Evidence & Research

No research papers or evidence available for this product.

Source: public | First published: May 26, 2022 | Last updated: Jul 21, 2025